Hepatocellular Carcinoma - Liver Cell Dysplasia
"Liver Cell Dysplasia is a Major Risk Factor for Hepatocellular Carcinoma in Cirrhosis: A Prospective Study."
Published in Hepatitis Weekly, April 17th, 1995
According to the authors' abstract of an article published in Gastroenterology, "Background/Aims: In humans, the role of liver cell dysplasia as a preneoplastic lesion is still debated. A prospective, long-term, multicenter study was performed to establish whether liver cell dysplasia in cirrhosis is associated with an increased risk for hepatocellular carcinoma (HCC). Methods: A cohort of 307 consecutive patients in whom liver cirrhosis was diagnosed by histology was investigated for development of HCC at 6-month intervals by ultrasonography and determination of alpha-fetoprotein levels. Results: At enrollment, liver cell dysplasia was found in 75 patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1995-04-17)
More Articles from Hepatitis Weekly
- Virology
Immunologic Abnormalities in Chronic HCV Patients Is High - Blood Banking
Autologous Blood Donation May Have Limited Value - Diagnostics
Need Exists for Improved HCV Antibody Tests - Education
CW Henderson Now Largest Publisher of Health Weeklies - Infection Control
Canada Red Cross Targets HIV - Virology/Hepatitis C
Genotype Among Factors to Consider in Managing Infection - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
